MACOM Announces Repayment of $ 100 Million in Outstanding Term Loans

LOWELL, Mass .– () – MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced that it will use $ 100 million of its cash flow and available cash equivalents and short-term investments to repay part of its outstanding term loans. Term loans are secured and have an original maturity date of May 2024.

“Reducing debt and interest expense is a priority,” said Stephen G. Daly, President and CEO. “Our strategy is to strengthen our product portfolio while improving profitability. ”

About MACOM

MACOM designs and manufactures semiconductor products for telecommunications, industrial and defense and data center applications. Based in Lowell, MA, MACOM has design centers and sales offices in North America, Europe and Asia. MACOM is certified to ISO9001 international quality standard and ISO14001 environmental management standard.

Special Note Regarding Forward-Looking Statements

This press release contains forward-looking statements based on the beliefs and assumptions of MACOM’s management and on information currently available to our management. These forward-looking statements include, among other things, statements regarding the expected repayment of a portion of MACOM’s outstanding term loans and its strategy.

These forward-looking statements reflect MACOM’s current views on future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause such events or our actual activities or results to differ materially from those indicated by forward-looking statements, including any failure to anticipate demand for our products; the risks associated with any weakening of economic conditions, in particular due to the COVID-19 pandemic; our dependence on a limited number of clients; our ability to develop new products and gain market acceptance for those products; disruptions in our supply chain; and the other factors described in the “Risk Factors” section in documents filed by MACOM with the Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K, its quarterly reports on Form 10- Q and other documents filed with the SEC. These forward-looking statements speak only as of the date of this press release, and MACOM assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events. or otherwise.

Source link

About Mariel Baker

Check Also

Can this Item 1 keep Vaxart in the coronavirus vaccine race?

Vaxart‘s (NASDAQ: VXRT) stocks plunged 58% in one trading session after a point in a …